Results 111 to 120 of about 9,592 (218)

First-in-Human Phase I Study to Evaluate the Brain-Penetrant PI3K/mTOR Inhibitor GDC-0084 in Patients with Progressive or Recurrent High-Grade Glioma. [PDF]

open access: yes, 2020
PurposeGDC-0084 is an oral, brain-penetrant small-molecule inhibitor of PI3K and mTOR. A first-in-human, phase I study was conducted in patients with recurrent high-grade glioma.Patients and methodsGDC-0084 was administered orally, once daily, to ...
Cloughesy, Timothy F   +11 more
core  

Biophysical characterization of histone H3.3 K27M point mutation [PDF]

open access: yes, 2018
K
Boros-Oláh, Beáta   +10 more
core   +1 more source

Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma

open access: yesNature Communications, 2016
Diffuse Intrinsic Pontine Gliomas are diagnosed by sampling a small portion of the tumour. Here, using multiple samples from tumours, the authors analyse the spatial and temporal distribution of driver mutations revealing that H3K27M mutations arise ...
Hamid Nikbakht   +23 more
doaj   +1 more source

A case of dural arteriovenous fistula showing high uptake on methionine positron emission tomography and mimicking diffuse intrinsic pontine glioma

open access: yesInterdisciplinary Neurosurgery
Background: Intracranial dural arteriovenous fistula (dAVF) and gliomas sometimes present with similar imaging findings. Methionine positron emission tomography (MET-PET) is used to diagnose gliomas; however, the findings for dAVF are unknown.
Yuki Sunohara   +8 more
doaj   +1 more source

Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma

open access: yesActa Neuropathologica Communications, 2017
Diffuse midline gliomas (including diffuse intrinsic pontine glioma, DIPG) are highly morbid glial neoplasms of the thalamus or brainstem that typically arise in young children and are not surgically resectable.
Tina Y. Huang   +8 more
doaj   +1 more source

Re-irradiation for progressive Diffuse Intrinsic Pontine Glioma (DIPG): The Spanish experience

open access: yesEJC Paediatric Oncology
Introduction: Diffuse intrinsic pontine glioma (DIPG) is the most common malignant brainstem tumour in children. Despite advances in understanding its biology, current treatments have shown minimal impact on overall survival in this fatal disease.
Elena Panizo-Morgado   +20 more
doaj   +1 more source

DIVERSet JAG compounds inhibit topoisomerase II and are effective against adult and pediatric high-grade gliomas [PDF]

open access: yes, 2019
High-grade gliomas (HGGs) are aggressive primary brain tumors with local invasive growth and poor clinical prognosis in both adult and pediatric patients.
Ajaz   +51 more
core   +2 more sources

Metastatic Diffuse Intrinsic Pontine Glioma to the Peritoneal Cavity Via Ventriculoperitoneal Shunt: Case Report and Literature Review

open access: yesJournal of Neurological Surgery Reports, 2015
Extraneural metastatic disease resulting from a primary central nervous system neoplasm is a rare clinical finding in the pediatric population. We report a case of peritoneal glioblastoma carcinomatosis following placement of a ventriculoperitoneal shunt
Ramon Francisco Barajas Jr.   +8 more
doaj   +1 more source

Abstracts

open access: yes
Cancer Science, Volume 117, Issue S1, Page 1-2148, January 2026.
wiley   +1 more source

Epigenetic Targeted Therapy for Diffuse Intrinsic Pontine Glioma

open access: yesNeurologia medico-chirurgica, 2017
Diffuse intrinsic pontine glioma (DIPG) is a rare but uniformly fatal cancer of the brain, with peak incidence in children of 5-7 years of age. In contrast to most types of human cancer, there has been no significant improvement in treatment outcomes for patients with DIPG.
openaire   +3 more sources

Home - About - Disclaimer - Privacy